CAMPATH 30MG INJECTION

Injection
Rs.86.25for 1 vial(s) (1 injection each)
1
Unfortunately, we don't have any more items in stock
Report Error

Composition FOR CAMPATH 30mg injection

Alemtuzumab(30mg)

food interaction for CAMPATH injection

alcohol interaction for CAMPATH injection

pregnancy interaction for CAMPATH injection

lactation interaction for CAMPATH injection

food
alcohol
pregnancy
lactation
It can be taken with or without food, but it is better to take Campath 30mg injection at a fixed time.
Interaction with alcohol is unknown. Please consult your doctor.
Campath 30mg injection may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
WEIGH RISKS VS. BENEFITS
Unknown. Human and animal studies are not available. Please consult your doctor.

SALT INFORMATION FOR CAMPATH 30mg injection

Alemtuzumab(30mg)

Campath injection uses

Campath 30mg injection is used in the treatment of blood cancer (chronic lymphocytic leukemia) and multiple sclerosis (ms).

How campath injection works

Campath 30mg injection flags the cancer cells for destruction by the body's immune system. It also modulates the immune system to limit its attacks on the nervous system.

Common side effects of campath injection

Rash, Headache, Insomnia (difficulty in sleeping), Nausea, Upper respiratory tract infection, Decreased white blood cell count, Fatigue, Fever, Itching, Flushing (sense of warmth in the face, ears, neck and trunk), Urticaria, Decreased white blood cell count (lymphocytes).

SUBSTITUTES FOR CAMPATH injection

No substitutes found

Top Medical Oncologists

Expert advice FOR CAMPATH injection

  • Alemtuzumab may sometimes cause life-threatening reactions like chest pain, breathlessness, slow or irregular heartbeat and therefore you will be closely monitored during and 2 hours after the infusion.
  • Seek immediate medication attention if you notice unusual bruising or bleeding, blood in urine, swelling of legs or feet, or if you cough up blood. 
  • Avoid activities that may increase your risk of bleeding or injury. Take necessary care to prevent bleeding while shaving or brushing your teeth. 
  • Serious infections may occur during alemtuzumab treatment. Inform doctor immediately if you develop fever, chills, cough, mouth sores, or trouble breathing.
  • Avoid contact with people who have infections.
  • Do not receive live vaccines if you have recently received alemtuzumab.
 

Frequently asked questions FOR CAMPATH 30mg injection

Alemtuzumab

Q. How is alemtuzumab administered?
Alemtuzumab is administered as an IV infusion over 2 hours (3mg/day) until infusion reactions are ≤grade 2, then 10mg/day on the alternate day and 30mg/day on the next alternate day. 30mg/day dose is continued every alternate day, for 12 weeks.
Q. Is alemtuzumab FDA approved for multiple sclerosis?
Yes, Alemtuzumab is FDA approved for Multiple sclerosis

Articles


Content on this page was last updated on 08 March, 2017, by Dr. Varun Gupta (MD Pharmacology)